Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1666 publications
Cancer Biopsy-United States Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Cancer Biopsy-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 139 pages
Cancer Biopsy-India Market Status and Trend Report 2013-2023 US$ 2,980.00

Report Summary Cancer Biopsy-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 154 pages
Cancer Biopsy-China Market Status and Trend Report 2013-2023 US$ 2,980.00

Report Summary Cancer Biopsy-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 142 pages
Cancer Biopsy-Asia Pacific Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Cancer Biopsy-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 136 pages
Cancer Biopsy-EMEA Market Status and Trend Report 2013-2023 US$ 3,480.00

... Cancer Biopsy-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market ... word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance ...

Dec, 2017 137 pages
Cancer Biopsy-Europe Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Cancer Biopsy-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 130 pages
Cancer Biopsy-South America Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Cancer Biopsy-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 138 pages
Cancer Biopsy-North America Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Cancer Biopsy-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 153 pages
Cancer Biopsy-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data US$ 3,680.00

... segments the global Cancer Biopsy market as: Global Cancer Biopsy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023): North America (United States ...

Dec, 2017 160 pages
Cancer Biopsy-Global Market Status and Trend Report 2013-2023 US$ 2,480.00

Report Summary Cancer Biopsy-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Biopsy industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 151 pages
Global Prostate Cancer Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

... to unawareness about prostate cancer symptoms is hampering the prostate cancer therapeutics market. Global prostate cancer therapeutics market segmented based on route of administration, drug class and distribution channel Based on drug class prostate cancer therapeutics market is segmented ...

Nov, 2017 197 pages
Global Cancer Gene Therapy Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023 US$ 4,400.00

... on the therapy, global cancer gene therapy market is segmented as: Retroviral Therapy Adenoviral Therapy Based on the end-user, global cancer gene therapy market is segmented as: Hospitals Oncology institutes Biotechnological companies Clinical Research Labs Global cancer gene therapy market is highly ...

Nov, 2017 209 pages
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2017 US$ 3,500.00

... Wilms Tumor Protein (WT33 or WT1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Nov, 2017 66 pages
Global Cancer Stem Cells (CSCs) Market Report 2017 US$ 2,350.00

... next few years, Cancer Stem Cells (CSCs) market size will be further expanded, we expect that by 2021, The market size of the Cancer Stem Cells (CSCs) will reach 10027 ...

Nov, 2017 140 pages
Global Head and Neck Cancer Diagnostics Market: Trend Analysis and Forecast to 2022 US$ 4,195.00

... considered to be the challenges faced by the global head and neck cancer diagnostics market. SEGMENTS COVERED: The global head and neck cancer diagnostics market based on diagnostic methods is segmented ...

Dec, 2016 100 pages
Prostate Cancer [2017] US$ 8,145.00

... Zytiga or Xtandi? Is the jury still out on immunotherapies in prostate cancer? Do KOLs believe that vaccine-based therapies or PD-1/PD-L1 checkpoint inhibitors ... Honorary Consultant in Clinical Oncology and Prostate Cancer Translational Research at The Institute of Cancer Research and The Royal Marsden, London ...

Oct, 2017
Prostate Cancer [2016]: Bulletin #3 US$ 1,045.00

... key opinion leader (KOL) insights on the latest events happening in prostate cancer.Topics covered include expert opinions on; the results of the Phase ... (cfDNA) can be used to assess treatment response in men with advanced prostate cancer who are administered with AstraZeneca's PARP inhibitor Lynparza (olaparib ...

Jul, 2017
Breast Cancer [2017]: Bulletin #1 US$ 1,045.00

... events that have the potential to impact the treatment landscape of breast cancer (BC). Topics covered include expert opinions on: Roche announcing results from ...

Aug, 2017
Bladder Cancer [2017] US$ 8,145.00

... to differentiate their marketed and pipeline therapies in KOL Insight: Bladder Cancer. Twelve US and European KOLs provide their candid insights on ... how do KOLs view Cyramza (ramucirumab) as a potential treatment for bladder cancer? What will be critical for commercial success in this indication? Which ...

Aug, 2017
Cancer Diagnostics Market 2021: Supplier Shares and Segment Sales Forecasts by Country, Competitive Profiles, Emerging Markers, Innovative Technologies, Instrumentation Review US$ 7,500.00 US$ 6,000.00

... global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. ... photonics spectroscopy. Profiles of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, ...

Nov, 2017 510 pages
Global Ovarian Cancer Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

Global Ovarian Cancer Treatment Market: Global ovarian cancer treatment market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for ovarian cancer treatment is projected to reach US$ XX Mn by 2023. Ovarian cancer is a type of cancer, which affects ovaries it ...

Nov, 2017 209 pages
Global Chronic Lymphocytic Leukemia Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

... Chronic Lymphocytic Leukemia Treatment Market: Global chronic lymphocytic leukemia treatment market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for chronic lymphocytic leukemia treatment is projected to reach US$ XX Mn by 2023. Chronic lymphocytic leukemia ...

Nov, 2017 216 pages
Global Cancer Monoclonal Antibodies Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

Global Cancer Monoclonal Antibodies Market: Global cancer monoclonal antibodies market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for cancer monoclonal antibodies is projected to reach US$ XX Mn by 2023. A monoclonal antibody drug in cancer treatments ...

Nov, 2017 210 pages
Global Bladder Cancer Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 US$ 4,400.00

... . Global bladder cancer treatment market is segmented based on cancer type, drug class, and distribution channel: Based on cancer type, global bladder cancer treatment market is segmented as: Transitional cell bladder cancer Invasive bladder cancer Superficial bladder cancer Squamous cell bladder cancer Other ...

Nov, 2017 218 pages
Global Cancer CDK Inhibitors Market & Clinical Pipeline Outlook 2022 US$ 2,200.00

... 45 CDK inhibitors are in various phases of clinical pipeline. “Global Cancer CDK Inhibitors Market & Clinical Pipeline Outlook 2022” report highlights: Selectivity & Working Mechanism of a Cancer CDKs Inhibitor Recent Advances in the CDKs Related Cancer Therapy Global Cancer CDK Inhibitors Clinical Trials ...

Nov, 2017 150 pages
CD Antigen Cancer Therapy Market Outlook & Clinical Trials Insight 2023 US$ 3,300.00

... cancer cells. “CD Antigen Cancer Therapy Market Outlook & Clinical Trials Insight 2023” report highlights: Market Opportunity Assessment: More than US$ 60 Billion by 2023 Clinical & Patent Insight on 17 Commercialize CD Antigen Drugs Clinical & Licensing Insight on 184 CD Antigens in Clinical ...

Oct, 2017 500 pages
IDO Inhibitors - A Pipeline Analysis Report US$ 3,500.00 US$ 2,500.00

... clinical and non-clinical trends in the global IDO inhibitors market. Most of the pipeline therapeutics are in early stage of development, the ... study, synthesis, and summation of data from multiple sources. Technavio's IDO Inhibitors - A Pipeline Analysis Report, has been prepared based on an in-depth market ...

Oct, 2017 70 pages
CAR T-cell Therapy for Multiple Myeloma – A Pipeline Analysis Report US$ 3,500.00 US$ 2,500.00

... (CAR) T-cell therapy for multiple myeloma: An insight The CAR T-cell therapy for multiple myeloma pipeline analysis report includes ongoing clinical and non-clinical trends in the global CAR T-cell therapy ...

Oct, 2017 70 pages
Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017' provides an overview of Human Papillomavirus (HPV) Associated Cancer clinical trials scenario. ...

Sep, 2017 101 pages
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Sep, 2017 76 pages
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Sep, 2017 73 pages
Hormone Refractory Breast Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Sep, 2017 42 pages
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H2, 2017' provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer clinical trials ...

Sep, 2017 970 pages
Pancreatic Cancer Diagnostics Using Artificial Intellgence Market Shares, Strategies, and Forecasts, Worldwide, 2017-2023 US$ 4,200.00

... the quantity of data is too high, so the artificial intelligence is being used to do that. Systems are making a significant difference ... to earlier cancer diagnosis.” Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts AI is set to become a sophisticated diagnostic aid, flagging ...

Oct, 2017 75 pages
Global Cancer Immunotherapy Market Analysis & Forecast to 2022Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen... US$ 4,900.00

... , Adectris, and Keytruda? What is the global market for cancer vaccines? What is the global market for cytokines in cancer immunotherapy? The projected market values for Nivolumab, Tecentriq, DCVax ...

Jan, 2017 370 pages
Global Non-invasive Cancer Diagnosis Market Research and Forecast 2017-2022 US$ 3,600.00 US$ 2,880.00

... and molecular diagnosis holds the largest market share in the non-invasive cancer diagnosis market. Global Non-Invasive Cancer Diagnosis market is bifurcated as follows: Global Non-Invasive cancer diagnosis Market Research and Analysis, by Type Global Non-Invasive cancer diagnosis Market Research and Analysis ...

Aug, 2017
Global Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023 US$ 2,400.00

... Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023” Highlights: Mechanism of Action of JAK/STAT Inhibitors Global Cancer JAK/STAT Inhibitor Market Outlook Global JAK/STAT Inhibitor Market Opportunity: US$ 4 Billion Global JAK/STAT Inhibitor in Pipeline: 27 Drugs Global Cancer JAK ...

Oct, 2017 190 pages
Global Radiation Oncology Market 2017-2021 US$ 3,500.00 US$ 2,500.00

... on geography: Americas APAC EMEA Technavio's report, Global Radiation Oncology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The ...

Sep, 2017 97 pages
Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets US$ 6,995.00

Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets SUMMARY Cancer is a group of diseases that are ... vaccination of the patient with tumor antigens, and non-specific immunotherapies, such as interferon therapy, which stimulate the immune system ...

Sep, 2017 135 pages
Head And Neck Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Aug, 2017 1563 pages
Prostate Cancer Therapeutics - Global Market Outlook (2017-2023) US$ 4,150.00

... Prostate Cancer Therapeutics market is estimated at $XX million in 2016 and is expected to reach $XX million by 2023 growing at a CAGR of XX% from 2016 to 2023. Increase in prostate cancer ... period because of government initiatives on creating awareness on prostate cancer. Some of the key players in the market ...

Jun, 2017 148 pages
Cancer Diagnostics - Global Market Outlook (2017-2023) US$ 4,150.00

... are favoring the Asia Pacific market growth. Some of the key players in global Cancer Diagnostics market include Abbott Diagnostics, Agilent Technologies, Inc., Becton, Dickinson ...

Sep, 2017 132 pages
Europe Cancer Diagnostics Market 2021: Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 19,700.00 US$ 15,760.00

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

Sep, 2017
Urinary Incontinence Devices Market in Japan 2017-2021 US$ 3,500.00 US$ 2,500.00

... drive the urinary incontinence devices market in Japan. The recent trend in urinary incontinence devices market includes a rise in government initiatives to increase awareness of incontinence-related issues and increasing R&D in developing urinary incontinence devices with ...

Sep, 2017 72 pages
Global Cancer Supportive Care Market 2017-2021 US$ 3,500.00 US$ 2,500.00

... -label drugs in cancer supportive care market. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Cancer Supportive Care Market 2017-2021, has ...

Sep, 2017 96 pages
Gallbladder Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Aug, 2017 181 pages
Fallopian Tube Cancer Global Clinical Trials Review, H2, 2017 US$ 2,500.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Aug, 2017 647 pages
Global Urinary Tract Cancer Industry Market Research Report US$ 2,960.00

... panorama of industrial development and characteristics of the Urinary Tract Cancer market. The Urinary Tract Cancer market can be split based on product types, ... major applications, and important regions. Major Players in Urinary Tract Cancer market are: Company 1 Company 2 Company 3 Company 4 ...

Sep, 2017 147 pages
Global Cervical Cancer Treatments Drug Industry Market Research Report US$ 2,960.00

... of the Cervical Cancer Treatments Drug market. The Cervical Cancer Treatments Drug market can be split based on product types, major applications, and important regions. Major Players in Cervical Cancer Treatments Drug market are ...

Sep, 2017 172 pages
Global Cancer/Tumor Profiling Industry Market Research Report US$ 2,960.00

... Cancer/Tumor Profiling market. The Cancer/Tumor Profiling market can be split based on product types, major applications, and important regions. Major Players in Cancer/Tumor Profiling market ... PCR Most widely used downstream fields of Cancer/Tumor Profiling market covered in this report are: Personalized ...

Sep, 2017 176 pages
1 2 3 4 5 >
Skip to top